BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 6365862)

  • 21. Tumor radiosensitization with concomitant bone marrow radioprotection: a study in mice using diethyldithiocarbamate (DDC) under oxygenated and hypoxic conditions.
    Evans RG
    Int J Radiat Oncol Biol Phys; 1985 Jun; 11(6):1163-9. PubMed ID: 2987165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Conference on chemical modification: radiation and cytotoxic drugs. Key Biscayne, Florida, 17-20 September, 1981.
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):323-815. PubMed ID: 7107349
    [No Abstract]   [Full Text] [Related]  

  • 23. Radiation and chemotherapy sensitizers and protectors.
    Coleman CN; Turrisi AT
    Crit Rev Oncol Hematol; 1990; 10(3):225-52. PubMed ID: 2257086
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chemical modification of radiation effects.
    Phillips TL
    Cancer; 1977 Feb; 39(2 Suppl):987-98. PubMed ID: 319901
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhancement of tumor radiation response by the combination of a perfluorochemical emulsion and hyperbaric oxygen.
    Martin DF; Porter EA; Rockwell S; Fischer JJ
    Int J Radiat Oncol Biol Phys; 1987 May; 13(5):747-51. PubMed ID: 3570898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radiation modifiers: treatment overview and future investigations.
    Thomas CT; Ammar A; Farrell JJ; Elsaleh H
    Hematol Oncol Clin North Am; 2006 Feb; 20(1):119-39. PubMed ID: 16580560
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of radiosensitizing drugs in the management of cancer.
    Adams GE
    Invest Cell Pathol; 1979; 2(4):303-8. PubMed ID: 396284
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemical radiation sensitizers and protectors: recent developments.
    Kim JH; Chu FC
    Clin Bull; 1981; 11(1):5-11. PubMed ID: 6268335
    [No Abstract]   [Full Text] [Related]  

  • 29. Can the therapeutic gain of radiotherapy be increased by concurrent administration of Asian botanicals?
    Sagar SM
    Integr Cancer Ther; 2010 Mar; 9(1):5-13. PubMed ID: 20042406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dose-response relationships for human tumors: implications for clinical trials of dose modifying agents.
    Williams MV; Denekamp J; Fowler JF
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1703-7. PubMed ID: 6237084
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combined use of radioprotective and radiosensitizing drugs in experimental radiotherapy.
    Yuhas JM; Yurconic M; Kligerman MM; West G; Peterson DF
    Radiat Res; 1977 May; 70(2):433-43. PubMed ID: 193145
    [No Abstract]   [Full Text] [Related]  

  • 32. Further evaluation of nicotinamide and carbogen as a strategy to reoxygenate hypoxic cells in vivo: importance of nicotinamide dose and pre-irradiation breathing time.
    Chaplin DJ; Horsman MR; Siemann DW
    Br J Cancer; 1993 Aug; 68(2):269-73. PubMed ID: 8347481
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical trials with hypoxic cell sensitizers: time to retrench or time to push forward?
    Urtasun RC; Coleman CN; Wasserman TH; Phillips TL
    Int J Radiat Oncol Biol Phys; 1984 Sep; 10(9):1691-6. PubMed ID: 6237083
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypoxic cell radiosensitizers.
    Fowler JF
    Strahlentherapie Sonderb; 1978; 75():12-9. PubMed ID: 400196
    [No Abstract]   [Full Text] [Related]  

  • 35. [Radiosensitization research in cancer therapy].
    Sugahara T
    Gan To Kagaku Ryoho; 1985 Mar; 12(3 Pt 1):405-11. PubMed ID: 3890755
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical results of hypoxic cell radiosensitisation from hyperbaric oxygen to accelerated radiotherapy, carbogen and nicotinamide.
    Saunders M; Dische S
    Br J Cancer Suppl; 1996 Jul; 27():S271-8. PubMed ID: 8763896
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemical modification of radiation and chemotherapy.
    Brown JM; Hall EJ; Hirst DG; Kinsella TJ; Kligerman MM; Mitchell JB; Travis EJ; Valeriote F
    Am J Clin Oncol; 1988 Jun; 11(3):288-303. PubMed ID: 3289362
    [No Abstract]   [Full Text] [Related]  

  • 38. Cancer trends: the potential of radiation modifiers.
    Elkon D
    Va Med; 1981 Feb; 108(2):120-4. PubMed ID: 7210858
    [No Abstract]   [Full Text] [Related]  

  • 39. Pentoxifylline improves the oxygenation and radiation response of BA1112 rat rhabdomyosarcomas and EMT6 mouse mammary carcinomas.
    Collingridge DR; Rockwell S
    Int J Cancer; 2000 Oct; 90(5):256-64. PubMed ID: 11091349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Developments in the experimental methods of evaluating hypoxic cell sensitizers].
    Shibamoto Y; Sasai K; Takahashi M; Abe M
    Gan No Rinsho; 1988 Oct; 34(13):1859-63. PubMed ID: 3199519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.